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In this specialty section of the journal, we host a topic focused
on thymic stromal alterations and genetic disorders of immune
system. The thymus is a specialized organ of the immune sys-
tem where, through stage-specific differentiation of hematopoietic
progenitor cells, fully mature and self-tolerant T cells origin. The
process is strictly dependent on the link between the thymic
stromal cells (TSCs), which allow the selection of a functional
and self-tolerant T-cell repertoire, and the thymus tridimensional
architecture. Indeed, the interaction between the developing thy-
mocytes and the stromal cells is crucial for the development of both
T cells and TSCs (1, 2). In both human and mice, the primordial
thymic epithelial cells (TECs) are yet unable to fully support the
T-cell development and only after the transcriptional activation
of the Forkhead-box n1 (FOXN1) gene, this essential function is
acquired. Most of the information concerning the T-cell develop-
ment came out from studies on mice carrying null mutation in
FOXN1 gene. In humans, as detailed in the Romano et al. review,
the Nude/SCID phenotype is characterized by congenital alopecia
of the scalp, eyebrows, and eyelashes, nail dystrophy, and a severe
T-cell immunodeficiency, inherited as an autosomal recessive dis-
order (3). As extensively approached in the Villa et al. review, the
intercellular cross-talk is also essential to support the maturation
of Foxp3C natural regulatory T cells. In Omenn syndrome (OS),
caused by hypomorphic Rag alterations, an infiltration of periph-
eral tissues by activated T cells and immune dysregulation have
been found (4). The authors discuss on abnormalities of thymic
microenvironment in OS with a special focus on the defective
maturation of TECs, and impairment of central tolerance.
The commonest association of thymic stromal deficiency
resulting in T-cell immunodeficiency is the DiGeorge syndrome
(DGS), discussed in the Davies review. In this syndrome, however,
the immunological impairment is highly variable, ranging from
normal to a severe immune defect in rare individuals, thus suggest-
ing that partial thymic hypoplasia may occur or that extrathymic
sites of differentiation play a role in the process (5). The difference
in the immunological defects between DGS and the Nude/SCID
phenotypes implies that FOXN1 controlled genes are mandatory
for a fully mature T-cell development process rather than the
integrity of the thymus itself.
It is known that autoimmune regulator (AIRE) gene plays a
central role in the induction of central tolerance, and different
mechanisms of action have been hypothesized for this process.
According to the most reliable theory, AIRE directly induces the
production of tissue-specific antigens (TSA) (6). However, recent
evidence suggests that another mechanism for negative selection
of self-reactive thymocytes may be due to AIRE-induced differ-
entiation of medullary TECs, and regulation of the expression
of intrathymic chemokines directed to antigens presenting cells
(APCs), such as thymocytes and dendritic cells (7). In their reviews,
Laan and Peterson and Kisand et al. give an overview on what
is known about the different mechanisms through which AIRE
induces central tolerance.
The process aimed at the elimination of potential self-reactive
T cells in the thymus is crucial for preventing the onset of autoim-
mune diseases. As discussed in the Akiyama et al. paper, medullary
epithelial cells play a central role in the process through the regula-
tion of gene expression, and, in particular, of those genes encoding
for the TNF family cytokines,RANK ligand,CD40 ligand,and lym-
photoxin. These genes promote the differentiation of AIRE- and
TSA-expressing mTECs (8).
The mechanism by which a single AIRE gene can influence the
transcription of such a large number of TSA within mTECs has
been discussed in the Matsumoto et al. paper. Two models have
been proposed. The first one implies a direct transcriptional con-
trol of AIRE on TSA, while the second one is based on the role of
AIRE on the maturation program of mTECs (9).
The clinical and immunological phenotype of patients affected
with autoimmune polyendocrinopathy ectodermal dystrophy
(APECED), as reviewed by Petteri Arstila and Jarva, is char-
acterized by multiple endocrine deficiencies, the most com-
mon manifestations being hypoparathyroidism, Addison’s disease,
hypogonadism, and secondary amenorrhea, usually associated
with the presence of autoantibodies toward the target tissues (10).
However, the phenotype and, therefore, the underlying pathogenic
mechanism, are even more complex, in that Chronic Mucocuta-
neous Candidiasis is also a prominent part of the disease. This
clinical entity is related to abnormalities in the Th17-related
cytokines, which are mostly involved in immune defenses against
Candida (11). Finally, high titers of neutralizing autoantibodies
against type I interferons, which have been shown to downreg-
ulate the expression of interferon-controlled genes, have been
documented (12).
In this Research Topic, De Martino et al. focus their attention on
the complexity of the APECED phenotype in that a wide variabil-
ity of the clinical expression, in the presence of the same genotype
alteration, has been found (13). They suggest that additional
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mechanisms, in addition to AIRE function, are involved in the
pathogenesis of the disease. This might be helpful to understand
not only the molecular basis of APECED but will also help improve
diagnosis, management, and therapeutic strategies to treat this
complex disease.
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